Empreendimentos Pague Menos S.A. (BVMF:PGMN3)
Brazil · Delayed Price · Currency is BRL | Market Cap | 2.25B +4.0% |
| Revenue (ttm) | 15.34B +16.9% |
| Net Income | 307.53M +112.2% |
| EPS | 0.48 +103.7% |
| Shares Out | 719.24M |
| PE Ratio | 6.56 |
| Forward PE | 5.52 |
| Dividend | 0.22 (6.50%) |
| Ex-Dividend Date | Dec 26, 2025 |
| Volume | 3,775,400 |
| Open | 3.200 |
| Previous Close | 3.190 |
| Day's Range | 3.090 - 3.200 |
| 52-Week Range | 3.110 - 7.620 |
| Beta | -0.04 |
| Analysts | Buy |
| Price Target | 6.88 (+119.81%) |
| Earnings Date | Aug 3, 2026 |
About BVMF:PGMN3
Empreendimentos Pague Menos S.A. operates a prominent pharmacy chain across Brazil, offering a comprehensive array of health and wellness products. Their extensive inventory includes a wide variety of medications spanning numerous therapeutic categories such as pain relief, allergy treatment, digestive health, diabetes management, and vitamins. Beyond pharmaceuticals, the company provides a vast selection of personal care and beauty products, dermo-cosmetics, and specialized items for mothers and babies. They also stock general merchandise, inc... [Read more]
Financial Performance
In 2025, BVMF:PGMN3's revenue was 14.91 billion, an increase of 17.91% compared to the previous year's 12.64 billion. Earnings were 260.28 million, an increase of 152.46%.
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for PGMN3 stock is "Buy." The 12-month stock price target is R$6.88, which is an increase of 119.81% from the latest price.
News
Empreendimentos Pague Menos Earnings Call Transcript: Q1 2026
Q1 2026 saw 14.4% revenue growth, 36% EBITDA growth, and net income quadrupling year-over-year, with strong market share gains in the North and Northeast and a focus on continuous care customers. Margin expansion, disciplined capital allocation, and digital growth underpin a positive outlook.
Empreendimentos Pague Menos Earnings release: Q1 2026
Empreendimentos Pague Menos released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Empreendimentos Pague Menos Slides: Q1 2026
Empreendimentos Pague Menos has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Empreendimentos Pague Menos Document: Q1 2026
Empreendimentos Pague Menos filed a regulatory document on May 5, 2026 disclosing important business information.
Empreendimentos Pague Menos Earnings Call Transcript: Q4 2025
Achieved record revenue and EBITDA growth in 2025, driven by strong same-store sales, digital expansion, and operational efficiency. Market share and profitability improved, with disciplined capital allocation and a focus on scaling logistics and generics in 2026.
Empreendimentos Pague Menos Earnings release: Q4 2025
Empreendimentos Pague Menos released its Q4 2025 earnings on March 2, 2026, summarizing the period's financial results.
Empreendimentos Pague Menos Slides: Q4 2025
Empreendimentos Pague Menos has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 2, 2026.
Empreendimentos Pague Menos Earnings Call Transcript: Q3 2025
Revenue grew 18% year-over-year, with same-store sales up 17.6% and EBITDA rising 36.4%. Prescription and generic drugs drove growth, while net income increased 50%. Market share, customer base, and store productivity all improved, with further gains expected.
Empreendimentos Pague Menos Earnings release: Q3 2025
Empreendimentos Pague Menos released its Q3 2025 earnings on November 4, 2025, summarizing the period's financial results.
Empreendimentos Pague Menos Slides: Q3 2025
Empreendimentos Pague Menos has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 4, 2025.
Empreendimentos Pague Menos Document: Q3 2025
Empreendimentos Pague Menos filed a regulatory document on November 4, 2025 disclosing important business information.
Empreendimentos Pague Menos Earnings Call Transcript: Q2 2025
Record revenue and profit growth driven by strong prescription drug sales, digital expansion, and operational excellence. Market share and productivity gains outpaced industry peers, with digital now 18.7% of sales and ROIC at 22.9%.
Empreendimentos Pague Menos Earnings release: Q2 2025
Empreendimentos Pague Menos released its Q2 2025 earnings on August 5, 2025, summarizing the period's financial results.
Empreendimentos Pague Menos Document: Q2 2025
Empreendimentos Pague Menos filed a regulatory document on August 5, 2025 disclosing important business information.